https://farsalinos.github.io/en/tags/copd/Recent content in COPD on FarsalinosHugo -- gohugo.ioen© 2026 K. Farsalinos, MD, MPH, PhD | Science & Public HealthThu, 24 Sep 2026 01:46:37 +0300https://farsalinos.github.io/en/science-deep-dives/ecig-copd-en/Tue, 22 Sep 2026 00:00:00 +0000https://farsalinos.github.io/en/science-deep-dives/ecig-copd-en/<h2 class="relative group">The Study at a Glance <div id="the-study-at-a-glance" class="anchor"></div> <span class="absolute top-0 w-6 transition-opacity opacity-0 -start-6 not-prose group-hover:opacity-100 select-none"> <a class="text-primary-300 dark:text-neutral-700 !no-underline" href="#the-study-at-a-glance" aria-label="Anchor">#</a> </span> </h2> <p>Researchers at the University of Kansas ran a 12-week pilot trial with 46 COPD patients who smoke and had no intention of quitting with approved methods. Everyone got a pod-based e-cigarette with 5% nicotine, in menthol or tobacco flavor, plus basic switching support. No control arm. No pharmacotherapy comparison. At week 12, there were two outcome groups:</p>